SEARCH

SEARCH BY CITATION

References

  • 1
    Simpson, AR. Introduction. The Nursling P. Budin. London : Caxton Publishing Co, 1907, xix.
  • 2
    ReedDM, StanleyFJ, editors. The Epidemiology of Prematurity. Baltimore , Maryland : Urban & Schwarzenberg, pp. 177192.
  • 3
    Yllpö A. Zur Physiologie, Klinik und zum Schicksal der Frühgeborenen. Z Kinderheilk 1920;24: 1110.
  • 4
    McKeown T, Record RC. Observations on fetal growth in multiple pregnancy. J Endocrinol 1952;8: 386401.
  • 5
    Abramson D, Reid DE. Use of relaxin in treatment of threatened premature labor. J Clin Endocrinol 1955;15: 206209.
  • 6
    Bishop EH, Woutersz TB. Arrest of premature labor. J Am Med Assoc 1961;178: 116.
  • 7
    Mosler KH. Symposion über Physiologie und Pathologie der Wehentätigkeit. Zentralblatt Für Gynäkologie, 1965.
  • 8
    World Health Organisation. Prevention of perinatal morbidity and mortality. Public Health Papers No. 42. Geneva: World Health Organization, 1969.
  • 9
    Decker WH, Thwaite W, Bordat S, Kayser R, Harami T, Campbell J. Some effects of relaxin in obstetrics. Obstet Gynecol 1958;12: 3746.
  • 10
    McCarthy JJ, Erving HW, Laufe LE. Preliminary report on the use of relaxin in the management of threatened premature labor. Am J Obstet Gynecol 1957;74: 134138.
  • 11
    Fuchs F, Fuchs AR, Poblete VK, Jr Risk A. Effect of alcohol on threatened preterm labor. Am J Obstet Gynecol 1967;99: 627637.
  • 12
    Fuchs AR, Fuchs F. Ethanol for prevention of preterm birth. Semin Perinatol 1981;5: 236251.
  • 13
    Dumont M. Traitement des douleurs utérine gravidiques par le lactate de magnésium. Lyon Méd 1965;213: 15711582.
  • 14
    The Magpie Trial Collaboration GroupDo women with pre-eclampsia, and their babies benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359: 18721873.
  • 15
    Andersson KE, Ingemarsson I, Ulmsten U, Wingerup L. Inhibition of prostaglandin-induced uterine activity by nifedipine. Br J Obstet Gynaecol 1979;86: 175179.
  • 16
    Jung H. General remarks on treatment with betamimetics. In: JungH, LambertiG, editors Beta-mimetic Drugs in Obstetrics and Perinatology. Stuttgart : Georg Thieme, 1982.
  • 17
    Weidinger H, Weist W. Tocolysis. Fortschr Med 1976;94: 299302.
  • 18
    Halle H, Hengst P. Zusatztokolyse durch Prostaglandinsythetasehemmung mit Indometacin. Z Geburtshilfe Perinatol 1978;182: 367370.
  • 19
    Trolp R, Irmer M, Bernius U, Pohl C, Steim H, Hillemanns HG. Tokolyseerfolge unter Fenoterol-Monotherapie und Fenoterol in Kombination mit einem kardioselektiven β-Blocker. Geburtshilfe Frauenheilkd 1980;40: 602609.
  • 20
    Spätling L. Orale Magnesium-Zusatztherapie bei vorzeitiger wehentätigkeit. Geburtshilfe Frauenheilkd 1981;41: 101102.
  • 21
    The Canadian Preterm Labor Investigators GroupTreatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992;327: 308312.
  • 22
    King JF, Keirse MJNC, Grant A, Chalmers I. Tocolysis—the case for and against. In: BeardRW, SharpF editors. Preterm Labour and its Consequences. London : Royal College of Obstetricians and Gynaecologists, 1985: 199208.
  • 23
    King JF, Grant A, Keirse MJNC, Chalmers I. Beta-mimetics in preterm labour: a pooled analysis of the randomised controlled trials. Br J Obstet Gynaecol 1988;95: 211222.